Prudential PLC maintained its stake in Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 400,000 shares of the oil and gas company’s stock at the close of the second quarter. Prudential PLC owned about 0.91% of Core Laboratories N.V. worth $40,508,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Parallel Advisors LLC raised its stake in shares of Core Laboratories N.V. by 33.4% during the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of Core Laboratories N.V. during the first quarter worth approximately $106,000. FNY Managed Accounts LLC bought a new stake in shares of Core Laboratories N.V. during the first quarter worth approximately $123,000. Shine Investment Advisory Services Inc. bought a new stake in shares of Core Laboratories N.V. during the second quarter worth approximately $134,000. Finally, First Bank & Trust raised its stake in shares of Core Laboratories N.V. by 5.8% during the second quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock worth $152,000 after buying an additional 82 shares during the last quarter.

CLB has been the subject of a number of recent research reports. BidaskClub raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 13th. Royal Bank Of Canada set a $145.00 price target on shares of Core Laboratories N.V. and gave the stock a “buy” rating in a research note on Saturday, June 17th. Morgan Stanley reissued an “overweight” rating and set a $130.00 price target (down from $150.00) on shares of Core Laboratories N.V. in a research note on Wednesday, June 21st. Zacks Investment Research downgraded shares of Core Laboratories N.V. from a “hold” rating to a “strong sell” rating in a research note on Monday, July 17th. Finally, Piper Jaffray Companies set a $97.00 price target on shares of Core Laboratories N.V. and gave the stock a “hold” rating in a research note on Wednesday, July 26th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $113.36.

Shares of Core Laboratories N.V. (CLB) traded down 0.09% during midday trading on Thursday, reaching $95.96. 55,073 shares of the company’s stock traded hands. The stock has a market cap of $4.24 billion, a P/E ratio of 58.87 and a beta of 1.64. Core Laboratories N.V. has a 52-week low of $86.55 and a 52-week high of $125.83. The stock has a 50-day moving average price of $93.23 and a 200-day moving average price of $102.92.

Core Laboratories N.V. (NYSE:CLB) last released its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. During the same quarter last year, the business earned $0.35 EPS. The company’s revenue was up 10.7% compared to the same quarter last year. Analysts forecast that Core Laboratories N.V. will post $1.99 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Core Laboratories N.V. (CLB) Position Maintained by Prudential PLC” was posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/core-laboratories-n-v-clb-position-maintained-by-prudential-plc/1610373.html.

Core Laboratories N.V. Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.